Sexually Transmitted Infections最新文献

{"title":"Sexually transmitted infections after implementation of doxycycline postexposure prophylaxis.","authors":"Hyman M Scott, Jorge Roman, Matthew Spinelli, Jason Bena, Thiago Torres, David Glidden, Susan Buchbinder","doi":"10.1136/sextrans-2025-056674","DOIUrl":"10.1136/sextrans-2025-056674","url":null,"abstract":"<p><strong>Objectives: </strong>Doxycycline as bacterial sexually transmitted infection (STI) postexposure prophylaxis (DoxyPEP) has shown high efficacy in clinical trials. We evaluated the impact of DoxyPEP on chlamydia (CT), gonorrhoea (GC) and syphilis incidence among pre-exposure prophylaxis (PrEP) users in a sexual health clinic in San Francisco, California, USA.</p><p><strong>Methods: </strong>DoxyPEP was offered to all PrEP clients at routine clinical visits starting on 30 November 2022. We included PrEP clients who received DoxyPEP (DoxyPEP users) or never initiated DoxyPEP (non-DoxyPEP users). Among DoxyPEP users, the 'pre-DoxyPEP' period was from 1 June 2022 until DoxyPEP initiation, and the 'post-DoxyPEP' period started after DoxyPEP initiation through 7 September 2023. STI testing included three sites-GC, CT and early syphilis testing. STI incidence rate ratios (IRRs) per quarter were evaluated using a pre-analysis, post-analysis and a controlled interrupted time series (CITS) analysis, with mixed-effects Poisson regression used to evaluate intervention effects.</p><p><strong>Results: </strong>Among 3081 PrEP clients, 1209 (39%) initiated DoxyPEP. During the pre-DoxyPEP period, any STI, CT, GC and syphilis mean quarterly positivity was 18.1%, 9.2%, 8.1% and 2.2% among DoxyPEP users and 7%, 3.2%, 3% and 0.7% among non-DoxyPEP users, respectively. In pre-implementation and post-implementation analysis of DoxyPEP users, DoxyPEP was associated with lower STI incidence for any STI (IRR 0.42, 95% CI 0.24 to 0.74, p=0.003), CT (IRR 0.33, 95% CI 0.23 to 0.46, p<0.001) and syphilis (IRR 0.22, 95% CI 0.07 to 0.54, p=0.001), but not GC (IRR 0.89, 95% CI 0.69 to 1.15, p=0.383). In a CITS analysis, DoxyPEP was associated with a significant decline in any STI incidence (0.67, 95% CI 0.46 to 0.96, p<0.030).</p><p><strong>Conclusions: </strong>Observed DoxyPEP uptake reflected strong demand among PrEP users when offered in a clinical setting. Overall, STI incidence declined rapidly after implementation, demonstrating the high impact of this intervention in a real-world setting. Continued evaluation of uptake, adherence and impact on bacterial STIs will be essential as DoxyPEP implementation expands.</p>","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":" ","pages":"322-324"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13585041/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Seek and you shall find! Prevalence and trends of chlamydial and gonococcal infections in a high-density urban area in Italy around the COVID era: a laboratory-based survey.","authors":"Marco Montalti, Marielle Ezekielle Djusse, Tiziana Lazzarotto, Simone Ambretti, Claudio Foschi, Davide Gori, Antonella Marangoni","doi":"10.1136/sextrans-2025-056666","DOIUrl":"10.1136/sextrans-2025-056666","url":null,"abstract":"<p><strong>Background: </strong>A comprehensive understanding of the epidemiology of <i>Chlamydia trachomatis</i> (CT) and <i>Neisseria gonorrhoeae</i> (NG) infections is essential for developing effective prevention strategies. This retrospective, laboratory-based study assessed the prevalence and trends of CT and NG infections in a densely populated area in northern Italy between 2018 and 2023.</p><p><strong>Methods: </strong>We collected data on all samples submitted to the Microbiology of IRCCS Azienda Ospedaliero-Universitaria of Bologna for CT/NG testing. Data were stratified by year, sex, age, testing site and anatomical sampling site.</p><p><strong>Results: </strong>A total of 63 569 samples from 46 501 individuals were analysed. CT prevalence was 7.2%, with a peak in those aged 18-25 and a male-to-female ratio of 1.56. Although one-third of tests were from family counselling centres or gynaecologists, the highest CT positivity was found at the STI outpatient clinic (69%) and infectious diseases centres (13%). NG prevalence was 4.8%, with very low rates in family and gynaecology settings. NG showed a striking male predominance (M:F=8.6). For both CT and NG, we observed (1) a rise in case numbers over time, especially in males; (2) a decline during the COVID-19 pandemic followed by a rebound; and (3) a notable proportion of pharyngeal and rectal infections.</p><p><strong>Conclusions: </strong>This study highlights key epidemiological trends of CT and NG infections based on population characteristics, healthcare access points and the influence of external factors such as COVID-19 pandemic. These findings underscore the importance of targeted screening and prevention programmes and reinforce the role of laboratory-based surveillance to guide public health interventions.</p>","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":"102 5","pages":"310-317"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13422061/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148472516","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Knowledge, attitudes and behaviours in relation to doxycycline post-exposure prophylaxis use among attendees and healthcare workers at two sexual health services in Ireland.","authors":"Amy Keane, Fiona Lyons, Colette J Smith, Diego Caixeta, Jean-Michel Molina, Giovanni Villa","doi":"10.1136/sextrans-2025-056565","DOIUrl":"10.1136/sextrans-2025-056565","url":null,"abstract":"<p><strong>Objectives: </strong>Doxycycline post-exposure prophylaxis (doxyPEP) has been shown to reduce syphilis and chlamydia incidence among gay, bisexual and other men who have sex with men (gbMSM) and transgender women (TGW). However, evidence among other populations remains limited. This study aimed to assess knowledge, attitudes, willingness and use of doxyPEP among sexual health clinic attendees and healthcare workers in Dublin.</p><p><strong>Methods: </strong>Data were collected via two anonymous surveys in two sexual health services for service users and healthcare workers. Surveys were collected between January and March 2024. Logistic regression analyses explored factors associated with willingness to use doxyPEP.</p><p><strong>Results: </strong>Among 378 clinic attendees (median age 32), 72% (272/378) identified as gbMSM, TGW, non-binary or gender fluid; 17% (64/378) cisgender women and 11% (42/378) heterosexual men. Overall, 62% (235/378) expressed willingness to use doxyPEP, with higher willingness observed in the gbMSM, TGW, non-binary and gender fluid group (70%, 190/272). This group also reported the highest level of knowledge of doxyPEP compared with other groups: 107/272 (39.3%). After adjustment, logistic regression analyses revealed that individuals with prior sexually transmitted infection (STI) diagnoses were more willing to use doxyPEP (adjusted OR (aOR) per number of STI diagnosed 2.00, 95% CI 1.28 to 3.03, p=0.002). 9% (35/378) reported doxyPEP use in the past 1 year. Among 52 healthcare workers, 81% (42/52) were aware of doxyPEP studies, 62% (32/52) believed it could reduce STIs, but 89% (46/52) had concerns, primarily around antimicrobial resistance.</p><p><strong>Conclusions: </strong>This is the first study evaluating doxyPEP attitudes in Ireland. Willingness to use doxyPEP was high among individuals at greatest STI risk, supporting its potential for targeted implementation. There was also interest among cisgender women and heterosexual men. However, clinician concerns about antimicrobial resistance remain a barrier. These findings highlight the need for national guidelines, ongoing surveillance and research, including among heterosexual men and cisgender women, to inform equitable and safe doxyPEP prescription.</p>","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":" ","pages":"318-321"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147942763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Willingness to participate in a long-acting injectable cabotegravir HIV pre-exposure prophylaxis study among men who have sex with men in the French ANRS-PREVENIR cohort.","authors":"August Eubanks, Maxime Hoyer, Abdourahmane Sow, Marion Mora, Lambert Assoumou, Lydie Beniguel, Jade Ghosn, Juan Camilo Jones, Dominique Costagliola, Bruno Spire, Jean-Michel Molina, Geoffroy Liegeon, Luis Sagaon-Teyssier, Christel Protière","doi":"10.1136/sextrans-2025-056662","DOIUrl":"10.1136/sextrans-2025-056662","url":null,"abstract":"<p><strong>Objectives: </strong>Despite the wide implementation of HIV oral pre-exposure prophylaxis (oPrEP), uptake, adherence and persistence issues remain. Long-acting injectable cabotegravir (CAB-LA) is a promising new PrEP HIV prevention option. However, little is known about oPrEP users' interest in it. We investigated men who have sex with men (MSM) oPrEP users' willingness to participate (WtP) in a CAB-LA PrEP study in France.</p><p><strong>Methods: </strong>We designed a cross-sectional questionnaire ('NewPrEP') to evaluate attitudes to CAB-LA of daily and event-driven oPrEP users participating in the ANRS-PREVENIR cohort study (2017-2025). The outcome, WtP, was dichotomised into 'Willing' (absolutely/probably) or 'Unwilling' (probably not/absolutely not/I would like to discuss this with my doctor before making a decision). We used multivariate logistic Bayesian model averaging to estimate factors associated with WtP.</p><p><strong>Results: </strong>Of the 1555 MSM followed in ANRS-PREVENIR in February 2023 with baseline data, 879 (57%) answered the NewPrEP questionnaire. Median age and follow-up time were 38 and 4.7 years, respectively; 37% and 22% were on daily- and event-driven oPrEP, respectively; 41% used a combination of both regimens. 64% had heard of CAB-LA PrEP, and 43% were WtP in a related study. Multivariate results showed that willing participants were younger and more likely to have heard of CAB-LA, to use daily oPrEP exclusively or in combination, to find it difficult to adhere to their regimen, to engage in chemsex, to trust their doctor and to be more interested in PrEP effectiveness than in the administration mode. They were less likely to perceive the obligatory 2-monthly hospital visits for CAB-LA PrEP as constraining, to be scared of injections and to fear long-acting medications.</p><p><strong>Conclusions: </strong>WtP in a CAB-LA study among MSM oPREP users was moderate but concentrated among those with the greatest need. This highlights the need to enable free distribution. Future studies should evaluate adherence and retention in long-acting iPrEP.</p>","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":" ","pages":"284-291"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145368721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Research news in clinical context.","authors":"Marina Daskalopoulou, Rachel Herbert, Giovanni Villa, Drieda Zace","doi":"10.1136/sextrans-2025-056817","DOIUrl":"https://doi.org/10.1136/sextrans-2025-056817","url":null,"abstract":"","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":"102 5","pages":"341-342"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148472496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Annual HIV incidence among gay, bisexual and other men who have sex with men in England, 2014 to 2023: a prospective cohort analysis using national surveillance data.","authors":"Natasha Ratna, Catriona Harrison, Tobi Kolawole, Eleanor Bell, Dana Ogaz, Alison Brown, John Saunders, Tamara Djuretic, Hamish Mohammed","doi":"10.1136/sextrans-2025-056695","DOIUrl":"10.1136/sextrans-2025-056695","url":null,"abstract":"<p><strong>Objectives: </strong>Following the fall in new HIV diagnoses in gay, bisexual and other men who have sex with men (GBMSM) since 2015, the English government published an HIV Action Plan in 2021 committing to end HIV transmission by 2030. Underlying HIV transmission and access to testing influence diagnosis trends and may not reflect incidence as people could be living with undiagnosed HIV for many years. We derived HIV incidence by clinical risk markers and pre-exposure prophylaxis (PrEP) use.</p><p><strong>Methods: </strong>Using GUMCAD STI surveillance data between 2014/2015 and 2022/2023, we calculated yearly HIV incidence among HIV-negative GBMSM attending sexual health services (SHS) in England with at least two HIV tests within 365 days ('repeat testers'). Annual incidence was stratified by clinical risk markers: bacterial sexually transmitted infection (STI) history and recent HIV test (from the previous year). Incidence was further stratified by PrEP use in 2022/2023.</p><p><strong>Results: </strong>The number of HIV-negative GBMSM attending SHS in England increased by 34% from 111 977 in 2014/2015 to 1 49 904 in 2022/2023, of whom repeat testers were 34% (37 576) in 2014/2015 and 38% (56 896) in 2022/2023. HIV incidence reduced by 93% overall (1.77/100 person-years (py) (95 CI 1.61 to 1.94) in 2014/2015 to 0.12/100 py (0.09 to 0.16) in 2022/2023). Incidence was reduced by at least 89% in all groups irrespective of clinical risk markers: with bacterial sexually transmitted infection (STI) history (3.68/100 py (3.17 to 4.27) to 0.26/100 py (0.18 to 0.38)); the subset with a rectal bacterial infection (5.18/100 py (4.13 to 6.49) to 0.58/100 py (0.36 to 0.93)) and with a recent HIV test (1.93/100 py (1.66 to 2.24) to 0.08/100 py (0.05 to 0.13)). In 2022/2023, using PrEP reduced HIV incidence by 86% (using PrEP: 0.05/100 py (0.03 to 0.08)) vs not using PrEP: 0.36/100 py (0.26 to 0.50)).</p><p><strong>Conclusion: </strong>There was a sustained and large decline in HIV incidence among GBMSM, while incidence remains highest among those with a recent bacterial STI history. This analysis further highlights the real-world impact of PrEP and highlights the importance of equitable provision of HIV combination prevention interventions.</p>","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":" ","pages":"329-332"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145669676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evolving global sexually transmitted infection guidance: translating evidence-based WHO recommendations into clinical practice.","authors":"Ismael Maatouk, Daniel McCartney, Teodora Wi, Francis Ndowa, Magnus Unemo","doi":"10.1136/sextrans-2025-056878","DOIUrl":"10.1136/sextrans-2025-056878","url":null,"abstract":"","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":" ","pages":"273-277"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147842450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Emergence of a ceftriaxone-resistant <i>Neisseria gonorrhoeae</i> strain harbouring <i>penA</i>-60.001 in a novel genetic background (MLST 9903) in Japan, 2018-2024.","authors":"Ken Shimuta, Yuki Ohama, Ai Yoshida, Shu-Ichi Nakayama, Makoto Ohnishi, Takuya Kawahata, Hideyuki Takahashi, Yukihiro Akeda","doi":"10.1136/sextrans-2025-056694","DOIUrl":"10.1136/sextrans-2025-056694","url":null,"abstract":"<p><strong>Objectives: </strong>The presence of gonococcal strains carrying the <i>penA</i>-60.001 allele has been reported worldwide. These strains can be resistant to ceftriaxone (CRO), which often leads to treatment failure. However, this strain has not been reported in Japan since 2017; therefore, its recent spread is not understood. Here, we report the emergence of CRO-resistant <i>Neisseria gonorrhoeae</i> and the strain carrying the <i>penA</i>-60.001 allele in Japan in recent years.</p><p><strong>Methods: </strong><i>N. gonorrhoeae</i> strains were identified during routine surveillance in the Kyoto-Osaka area of Japan between 2018 and 2024. Antimicrobial susceptibility testing was performed using the agar dilution method. Whole-genome sequencing (WGS) was performed using the MiSeq platform. A phylogenetic tree was constructed based on the core genome using IQ-TREE V.2.0.0, with the best-fit nucleotide substitution model being selected using the Bayesian information criterion. Transformation experiments were conducted to confirm that the gDNA of the CRO-resistant strain of <i>N. gonorrhoeae</i> could generate a new CRO-resistant strain.</p><p><strong>Results: </strong>Of the 1336 <i>N</i>. <i>gonorrhoeae</i> strains isolated in this study, 6 were resistant to CRO. WGS revealed that one of these CRO-resistant <i>N. gonorrhoeae</i> strains, IW642, exhibited multilocus sequence type (MLST) 9903. It also carried the <i>penA</i>-60.001. A similarity analysis of the <i>penA-murE</i> regions of IW642 and FC428 revealed complete sequence identity in the <i>penA</i> region. Through transformation experiments, we also demonstrated the ability of IW642 gDNA to produce new CRO-resistant strains of <i>N. gonorrhoeae</i>.</p><p><strong>Conclusions: </strong>An <i>N. gonorrhoeae</i> strain carrying the <i>penA</i>-60.001 allele was identified in Japan again, after not being reported since 2017. Based on a phylogenetic analysis, the strain originated from a different lineage than that of the previously dominant MLST 1903 strain in Japan. Transformation studies showed that new CRO-resistant <i>N. gonorrhoeae</i> strains could emerge from the gDNA of the MLST 9903 strain that was isolated.</p>","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":" ","pages":"325-328"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145564957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Should we still treat asymptomatic <i>Neisseria gonorrhoeae</i> and <i>Chlamydia trachomatis</i> contacts in the era of NAATs? Reviewing data from the GetaKit study to inform practice.","authors":"Patrick O'Byrne, Lauren Orser","doi":"10.1136/sextrans-2025-056697","DOIUrl":"10.1136/sextrans-2025-056697","url":null,"abstract":"<p><strong>Objectives: </strong>We sought to determine positivity rates for participants in the GetaKit study who identified as asymptomatic contacts of <i>Neisseria gonorrhoeae</i> (NG) and/or <i>Chlamydia trachomatis</i> (CT). Our goal was to shed light on current discrepancies between international sexually transmitted infection (STI) guidelines, some of which recommend blanket empiric treatment for all NG and CT contacts (eg, Canadian and United States guidelines) versus others which recommend waiting for positive results (BASHH, Australian, and European).</p><p><strong>Methods: </strong>We extracted data for the period of 1 June 2023 to 30 June 2025 from GetaKit, which is a research website through which persons in Ontario, Canada can complete an online risk assessment and obtain access to laboratory-based testing for STIs, including NG, CT, HIV, syphilis and hepatitis C. From these data, we calculated positivity rates for NG and CT and the numbers needed to treat. We also evaluated for correlations of risk factors for testing positive.</p><p><strong>Results: </strong>During our 25-month study period, participants ordered NG/CT testing 12 775 times. In a total of 6.7% of these orders, participants identified as an NG and/or CT contact. Positivity rates, for all completed testing, were 1.2% (n=115 diagnoses) for NG and 4.3% (n=395 diagnoses) for CT. Positivity among asymptomatic contacts ranged from 0% for NG in heterosexual males to 30.6% for CT in females who were ≤24 years old, with most positivity rates being <20% for both infections.</p><p><strong>Conclusions: </strong>Our results suggest that blanket recommendations to treat or defer treatment seems inappropriate. More nuance is required. Empiric treatment of all NG and CT contacts will likely result in mass overuse of antibiotics. In contrast, deferring treatment seems inappropriate for asymptomatic females who are ≤24 years old and for anyone who cannot immediately obtain testing and treatment.</p>","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":" ","pages":"278-283"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13422048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145303211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anal cancer screening: introduction into routine clinical care for key populations.","authors":"Troy Grennan, Tamzin Cuming","doi":"10.1136/sextrans-2025-056882","DOIUrl":"https://doi.org/10.1136/sextrans-2025-056882","url":null,"abstract":"","PeriodicalId":21624,"journal":{"name":"Sexually Transmitted Infections","volume":"102 5","pages":"343-344"},"PeriodicalIF":3.0,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148472513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}